BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
1.310
-0.070 (-5.07%)
At close: May 15, 2026, 4:00 PM EDT
1.350
+0.040 (3.05%)
After-hours: May 15, 2026, 7:45 PM EDT
BioVie Employees
BioVie had 13 employees as of June 30, 2025. The number of employees decreased by 1 or -7.14% compared to the previous year.
Employees
13
Change (1Y)
-1
Growth (1Y)
-7.14%
Revenue / Employee
n/a
Profits / Employee
-$1,535,386
Market Cap
9.88M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2025 | 13 | -1 | -7.14% | 13 | 0 |
| Jun 30, 2024 | 14 | -4 | -22.22% | 14 | 0 |
| Jun 30, 2023 | 18 | 5 | 38.46% | 18 | 0 |
| Jun 30, 2022 | 13 | 7 | 116.67% | 13 | 0 |
| Jun 30, 2021 | 6 | 2 | 50.00% | 6 | 0 |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| CytoMed Therapeutics | 43 |
| Lunai Bioworks | 29 |
| Imunon | 25 |
| Bolt Biotherapeutics | 23 |
| CalciMedica | 16 |
| Aprea Therapeutics | 8 |
| Ernexa Therapeutics | 7 |
| Quoin Pharmaceuticals | 6 |
BIVI News
- 9 days ago - BioVie Transcript: KOL event - Transcripts
- 19 days ago - BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson's Disease ahead of Topline Data in 2Q26, on May 7, 2026 - GlobeNewsWire
- 4 weeks ago - BioVie Transcript: Biotech Resurgence: Platforms and Pipelines of Today's Innovators - Transcripts
- 4 weeks ago - BioVie Announces Abstract Accepted for Presentation at the 2026 American Academy of Neurology Annual Meeting - GlobeNewsWire
- 2 months ago - BioVie Transcript: Status update - Transcripts
- 3 months ago - Halper Sadeh LLC Encourages BioVie Inc. Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewsWire
- 4 months ago - BioVie completes enrollment in Phase 2 SUNRISE-PD trial - TheFly
- 5 months ago - HALPER SADEH LLC ENCOURAGES BIOVIE INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PRNewsWire